带衍生中干细胞优先调节巨细胞以缓解肺纤维化
1State Key Laboratory of Membrane Biology, School of Basic Medical Sciencese, Institute of Precision Medicine, Tsinghua University, Beijing, 100084, China.
Stem cell research & therapy
|December 19, 2024
概括
带介质干细胞 (UCMSCs) 在治疗肺损伤方面显示出比胎盘介质干细胞 (PLMSCs) 更好的结果. UCMSCs促进M2巨细胞两极分化,在异常性肺纤维化模型中提供卓越的抗纤维效应.
科学领域:
- 再生医学是一种再生医学.
- 免疫学 免疫学 免疫学
- 肺部医学 肺部医学
背景情况:
- 异形性肺纤维化 (IPF) 是一种渐进的肺部疾病.
- 介质细胞干细胞 (MSCs) 在IPF治疗中受到探索.
- 带 (UCMSCs) 和胎盘 (PLMSCs) 衍生MSC之间的治疗疗效差异尚不清楚.
研究的目的:
- 为了比较UCMSCs和PLMSCs在肺损伤小鼠模型中的治疗效果.
- 研究UCMSCs和PLMSCs不同治疗潜力的基础机制.
主要方法:
- 使用了白素 (BLM) 诱导的肺损伤小鼠模型.
- 在体外和体内评估UCMSCs和PLMSCs之间的治疗差异.
- 分析了与炎症和巨细胞两极分化相关的基因表达.
主要成果:
- 与PLMSC相比,UCMSC在肺损伤上表现出更好的治疗效果.
- UCMSCs诱导了较高水平的与炎症相关的基因和M2巨细胞两极分化.
- 在UCMSC中,表现出化学因子 (CCL2,CXCL1) 和受影响的巨相关基因 (SPP1,Trem2,Cebpb) 的差异表达.
结论:
- UCMSCs在治疗肺损伤方面具有优异的抗纤维性质.
- 与PLMSC相比,UCMSC的增强疗效可能归因于它们诱导更强大的M2巨分化的能力.
相关概念视频
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K


